United Therapeutics Corporation - Company Profile and SWOT Analysis

January 2024 | 42 pages | ID: U3618C84983EN
MarketLine

Abstracts

United Therapeutics Corporation %li%Company Profile and SWOT Analysis

Summary

United Therapeutics Corporation %li%Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

Key Highlights

United Therapeutics Corporation (United Therapeutics or 'the company') is a biotechnology company focused on the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening conditions. The product portfolio of the company includes Remodulin injection; Tyvaso (treprostinil) inhalation solution; Adcirca (tadalafil) tablets; Unituxin (dinutuximab) injection, and Orenitram (treprostinil) extended-release tablets. Its product candidates include monoclonal antibodies (mAbs), glycobiology antiviral agents, and cell-based therapies. United Therapeutics sells products through specialty pharmaceutical distributors across the US. It operates in Europe, Israel and the Middle East, Asia, and South and Central America. The company is headquartered in Silver Spring, Maryland, the US.

Scope

• Detailed information on United Therapeutics Corporation required for business and competitor intelligence needs
• A study of the major internal and external factors affecting United Therapeutics Corporation in the form of a SWOT analysis
• An in-depth view of the business model of United Therapeutics Corporation including a breakdown and examination of key business segments
• Intelligence on United Therapeutics Corporation's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
• News about United Therapeutics Corporation, such as business expansion, restructuring, and contract wins
• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to Buy

• Gain understanding of United Therapeutics Corporation and the factors that influence its strategies.
• Track strategic initiatives of the company and latest corporate news and actions.
• Assess United Therapeutics Corporation as a prospective partner, vendor or supplier.
• Support sales activities by understanding your customers' businesses better.
• Stay up to date on United Therapeutics Corporation's business structure, strategy and prospects.

Contents

Table of Contents
Company Snapshot
United Therapeutics Corporation: Company Overview
United Therapeutics Corporation: Overview and Key Facts
United Therapeutics Corporation: Overview
United Therapeutics Corporation: Key Facts
United Therapeutics Corporation: Key Employees
United Therapeutics Corporation: Key Employee Biographies
United Therapeutics Corporation: Major Products and Services
United Therapeutics Corporation: Management Statement
United Therapeutics Corporation: Locations and Subsidiaries
United Therapeutics Corporation: Key Competitors
United Therapeutics Corporation: Company Analysis
United Therapeutics Corporation: Business Description
United Therapeutics Corporation: SWOT Analysis
United Therapeutics Corporation: SWOT Overview
United Therapeutics Corporation: Strengths
United Therapeutics Corporation: Weaknesses
United Therapeutics Corporation: Opportunities
United Therapeutics Corporation: Threats
United Therapeutics Corporation: Corporate Financial Deals Activity
United Therapeutics Corporation: Financial Deals Overview
United Therapeutics Corporation: Targets and Partners
United Therapeutics Corporation: Top Deals 2020 - 2024YTD*
United Therapeutics Corporation: Advisors
United Therapeutics Corporation: Top Legal Advisors
United Therapeutics Corporation: Mergers and Acquisitions
United Therapeutics Corporation: Partnership
United Therapeutics Corporation: Recent Developments
United Therapeutics Corporation: News and Events Summary
United Therapeutics Corporation: Financial Performance
United Therapeutics Corporation: Market Developments
United Therapeutics Corporation: Regulatory and Legal Events
United Therapeutics Corporation: Research & Development
United Therapeutics Corporation: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List Of Tables

LIST OF TABLES

Table 1: United Therapeutics Corporation: Key Facts
Table 2: United Therapeutics Corporation: Key Employees
Table 3: United Therapeutics Corporation: Locations and Subsidiaries
Table 4: United Therapeutics Corporation: Key Competitors
Table 5: United Therapeutics Corporation: Deal Activity by Deal Type - Volume (TTM*)
Table 6: United Therapeutics Corporation: M&A Activity by Geography (TTM*)
Table 7: United Therapeutics Corporation: Deal Activity by Deal Type - Volume (2020 - YTD*2024)
Table 8: United Therapeutics Corporation: M&A Average Deal Size - Value (US$m)
Table 9: United Therapeutics Corporation: Targets and Partners
Table 10: United Therapeutics Corporation: Top Deals 2020 - 2024YTD*
Table 11: United Therapeutics Corporation: Legal Advisor Ranking by Value (US$m)
Table 12: United Therapeutics Corporation: M&A Volume and Value Trend (2020 - YTD*2024)
Table 13: United Therapeutics Corporation: M&A Activity by Geography (2020 - YTD*2024)
Table 14: United Therapeutics Corporation: Partnership Volume and Value Trend (2020 - YTD*2024)
Table 15: United Therapeutics Corporation: Partnership Trend by Deal Type (2020 - YTD*2024)
Table 16: United Therapeutics Corporation: News and Events Summary
Table 17: United Therapeutics Corporation: Financial Performance
Table 18: United Therapeutics Corporation: Market Developments
Table 19: United Therapeutics Corporation: Regulatory and Legal Events
Table 20: United Therapeutics Corporation: Research & Development
Table 21: United Therapeutics Corporation: Strategy and Operations

List Of Figures

LIST OF FIGURES

Figure 1: United Therapeutics Corporation: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: United Therapeutics Corporation: M&A Activity by Geography (TTM*)
Figure 3: United Therapeutics Corporation: Deal Activity by Deal Type - Volume (2020 - YTD*2024)
Figure 4: United Therapeutics Corporation: M&A Average Deal Size - Value (US$m)
Figure 5: United Therapeutics Corporation: M&A Volume and Value Trend (2020 - YTD*2024)
Figure 6: United Therapeutics Corporation: M&A Activity by Geography (2020 - YTD*2024)
Figure 7: United Therapeutics Corporation: Partnership Volume and Value Trend (2020 - YTD*2024)
Figure 8: United Therapeutics Corporation: Partnership Trend by Deal Type (2020 - YTD*2024)